MedTech News

Cyborg-type robots can boost neuroplasticity when users control their own movement
Researchers at University of Tsukuba have demonstrated for the first time that brain regions responsible for high-level motor planning and preparation, such as the premotor cortex, are activated when a cyborg-type robot is volitionally controlled.

NHS offers artificial pancreas to pregnant women with type 1 diabetes in the UK
The NHS announced a first-of-its-kind initiative in England, offering automated insulin delivery systems for pregnant women with diabetes.

Pulse Biosciences wins FDA IDE to conduct study of nsPFA tech for AFib
Pulse Biosciences (Nasdaq:PLSE) announced today that the FDA granted investigational device exemption (IDE) for its nanosecond pulsed field ablation (nsPFA) system.

Lifeward wins CE mark for ReWalk 7 personal endoskeleton
Lifeward (Nasdaq:LFWD) announced today that it received CE mark approval for its ReWalk 7 personal exoskeleton.

Coral-inspired capsule samples hidden bacteria from the small intestine
In the depths of the ocean, marine corals have evolved intricate, porous structures that shelter diverse microbial communities. Now, researchers have borrowed this biological blueprint to create an ingestible pill that can sample bacteria from one of the most inaccessible regions of the human body: the small intestine.

Microfluidic platform with label-free sorting can assess neutrophil function in sepsis
Sepsis arises from infection and immune dysregulation. Neutrophils play a key role in its progression, yet existing clinical tools cannot simultaneously isolate these cells and measure their functional activity.

3D printing ‘glue gun’ can generate bone grafts directly onto fractures
Scientists have developed a tool made from a modified glue gun that can 3D print bone grafts directly onto fractures and defects during surgery.

Ultrasound helmet enables deep brain stimulation in people without surgery
An ultrasound device that can precisely stimulate areas deep in the brain without surgery has been developed by researchers from UCL and the University of Oxford, opening up new possibilities for neurological research and treatment of disorders such as Parkinson’s disease.